ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.140
+0.075 (7.04%)
At close: Nov 6, 2026, 4:00 PM EST
1.140
0.00 (-0.03%)
After-hours: Nov 6, 2026, 7:43 PM EST
ProKidney Stock Forecast
PROK's stock price has decreased by -57.78% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 6 analysts polled by S&P Global, ProKidney stock has a consensus rating of "Buy" and an average price target of $6.50. The average 1-year stock price forecast is 470.18% higher than the current stock price, while the lowest is $1.00 (-12.28%) and the highest is $12 (+952.63%).
Price Target: $6.50 (+470.18%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ProKidney stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jun '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +601.75% | Oct 29, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $12 | Buy | Maintains | $12 | +952.63% | Oct 28, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains $1 | Sell | Maintains | $1 | -12.28% | Oct 28, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 13, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $3 | Hold | Maintains | $3 | +163.16% | Aug 11, 2026 |
Financial Forecast
Revenue This Year
529.00K
from 893.00K
Decreased by -40.76%
Revenue Next Year
494.20K
from 529.00K
Decreased by -6.58%
EPS This Year
-0.58
from -0.52
EPS Next Year
-0.61
from -0.58
EPS and Forward PE are based on non-GAAP adjusted numbers.